You are here: Industry Insights > NMPA

News List

Block-buster Small Molecule Pharmaceuticals Approved by the NMPA in 2023 Yefenghong
March 06, 2024
According to data collated from the National Medical Products Administration (NMPA) official website, a total of more than 80 new drugs were granted inaugural approval within the domestic market.
How to register a drug into the market in China? ChatGPT/PharmaSources
November 08, 2023
Registering a drug for market approval in China involves a comprehensive and multi-step process that requires adherence to the country's regulatory requirements.
Drug Marketing in China and Worldwide (September)(2023) PharmaSources
October 01, 2023
For the importance of disease monoclonal antibodies, the drug ingredient is still being tested.
Drug Marketing in China and Worldwide (August)(2023) PharmaSources
September 01, 2023
The official website shows that the drugs developed by major companies have been declared for marketing.
Drug Marketing in China and Worldwide (June) Caicai/PharmaSources
July 12, 2023
Drug Marketing in China and Worldwide (June)
NMPA's Progress in Joining PIC/S zhulikou431/PharmaSources
July 12, 2023
This article will introduce China NMPA's progress in joining PIC/S and the latest change in GMP guideline of PIC/S respectively.
Drug Marketing in China and Worldwide (May) Caicai/PharmaSources
July 12, 2023
Drug Marketing in China and Worldwide (May)
Regulation and response to drug shortages in China PharmaSources/zhulikou431
June 12, 2023
China's regulation of and response to drug shortages.
The drug regulatory landscape in China: Progress and Reform Deborah Seah
April 20, 2023
Since 2015 when drug approval policies and process have begun its reform, China has seen improvements in both the speed and predictability of drug approvals over the past few years.
Pharma packaging regulations of NMPA, EMA and FDA Muhammad Asim Niazi
March 21, 2023
There are various regulatory bodies globally that take part in constituting packaging regulations. The pharma manufacturer is requires to comply with the regulations of body, in which it intends to produce or market its manufactured drug.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page